Recombinant Human Anti-MLANA Soluble TCR (199.54-16) (C-Cys) (CAT#: VS-0622-YF4697)
Human TCR (199.54-16) recognizes MLANA peptide (EAAGIGILTV) in the context of HLA-A2. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Specific Inquiry
Normal Tissue
RNA Expression
Figure 1 High expression in skin 1
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/48662/167996_B_8_1_val_selected.jpg
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/48662/167996_B_8_1_val_selected.jpg
Figure 2 Low expression in liver
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/48662/167996_A_8_4_val_selected.jpg
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/48662/167996_A_8_4_val_selected.jpg
Figure 3 Testis
(Leydig cells Staining: Not detected Intensity: Weak Quantity: <25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/48662/167996_A_5_6.jpg
(Leydig cells Staining: Not detected Intensity: Weak Quantity: <25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/48662/167996_A_5_6.jpg
Figure 4 RNA cell line category: Cell line enriched (SK-MEL-30)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000120215-MLANA
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000120215-MLANA
Specifications
- Host Species
- Human
- Target
- MLANA
- Species Reactivity
- Human
- Epitope
- EAAGIGILTV
- MHC
- HLA-A2
- Clone
- 199.54-16
- Type
- Soluble TCR (C-Cys)
- Related Disease
- Melanoma, Microphthalmia
- TCR Expression Strategy
- C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- Melan-A; Antigen LB39-AA; Antigen SK29-AA; Protein Melan-A; MART-1; MART1; Melanoma Antigen Recognized By T-Cells 1
- Gene ID
- 2315
- UniProt ID
- Q16655
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone 199.54-16"
See other products for "MLANA"
Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibodies
Single Domain Antibodies
Immunotoxins
MHC Tetramers for Cancer
Rabbit Monoclonal Antibodies
Epitope-Specific Antibodies
IHC Kits & Antibodies
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-1380z | Mouse Anti-MLANA Recombinant Antibody (clone 22A7) | ELISA, FC, ICC, IF, IHC, WB | Mouse IgG1 |
| MOB-0096F | Mouse Anti-MLANA Recombinant Antibody (MOB-0096F) | IHC-P, IF | Mouse IgG |
| VS3-XY1075 | Mouse Anti-MLANA Recombinant Antibody (clone 2F3B7) | ELISA, WB | Mouse IgG1 |
| VS3-XY1076 | Mouse Anti-MLANA Recombinant Antibody (clone 2F1) | ELISA, WB | Mouse IgG1 |
| VS3-FY930 | Recombinant Mouse Anti-MLANA Antibody (clone 4A9-1E7-10H2) | IHC-P | Mouse IgG2b |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF4697. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: ELISA, Neut, IF, IP, FC, FuncS
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: Neut, ELISA, Inhib, ICC, WB
-CB2006C17L-4.jpg)
Application: WB, ELISA
-3.jpg)
-2.png)
Application: WB, ELISA
Application: Block, IP, IF, FC
Application: ELISA, IF, Block, FuncS
Application: FC
Application: ELISA, FuncS, RIA, IP, IF, IHC, IA, Block
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
